BRUSSELS, BELGIUM / RankWire.AI / – In Brussels, during August, the European Commission announced a new initiative to acquire €2.1 million worth of PCR tests to combat the ongoing Bundibugyo Ebola outbreak. These versatile open-platform tests are intended to bolster infection detection efforts and enhance laboratory capacity amidst the emergency. The procurement was coordinated with assistance from the European Health and Digital Executive Agency, with shipments scheduled to start in August, providing vital diagnostic supplies as health authorities face increasing case numbers in the Democratic Republic of the Congo.
The PCR testing kits will be sent to the World Health Organization’s Hub for Global Health Emergencies Logistics based in Dubai. WHO will oversee the distribution to the regions involved in Ebola response activities. PCR testing is crucial for confirming infections, as laboratories can handle large sample volumes with high precision. Additionally, this equipment integrates seamlessly with existing laboratory infrastructure. Rapid confirmation of cases allows health teams to identify infected patients promptly, facilitate appropriate treatment and isolation, and conduct contact tracing around confirmed cases.
This procurement follows a separate agreement by the European Commission, which allocated €2.5 million for rapid molecular point-of-care testing devices and instruments. These supplies are intended to aid the Africa Centres for Disease Control and Prevention. Collectively, these two agreements raise the European Union’s diagnostic support funding to €4.6 million. These measures are part of a broader European effort to respond to the Bundibugyo virus crisis, which has increasingly strained health systems in affected parts of Central and East Africa.
Diagnostic capacity expands amid escalating outbreak
By August 12, WHO reported that the Democratic Republic of the Congo had documented 4,665 confirmed cases and 2,184 deaths. The outbreak has affected 54 health zones across six provinces, including Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo, and Bas-Uélé. WHO described this as the largest Ebola outbreak ever recorded in the country. The agency also highlighted that transmission remains intense, with interconnected geographic clusters facilitating ongoing spread within affected areas.
On August 14, WHO maintained its highest national risk assessment for the Democratic Republic of the Congo, categorizing the risk for neighboring nations as high and for other countries as low. The agency released updated temporary guidelines on August 24 after convening its International Health Regulations Emergency Committee for a second meeting. These guidelines cover surveillance, case detection, infection prevention, clinical management, community engagement, and measures related to domestic movement and mass gatherings.
European support now totals €493 million
The European Commission announced the mobilization of €493 million to support emergency responses, vaccines, treatments, and health security initiatives across the Great Lakes region and Uganda. European health authorities continue to back surveillance, laboratory work, and preparedness activities during this outbreak. The European Centre for Disease Prevention and Control continues to rate the risk to Europe as very low, citing the low likelihood of sustained transmission and the need for close contact with infectious fluids.
The Bundibugyo outbreak remains designated a public health emergency of international concern, a status declared by WHO on May 17. Unlike the more frequently encountered Zaire ebolavirus, no approved vaccine or specific treatment exists for the Bundibugyo virus. WHO emphasizes essential response measures such as surveillance, rapid diagnosis, patient isolation, clinical care, infection control, and contact monitoring. The latest PCR procurement by the European Commission enhances laboratory capacity for these efforts, with WHO and Africa CDC coordinating health operations alongside national authorities in affected and nearby regions.